# Eclampsia

Eclampsia is a seizure emergency in pregnancy or postpartum. Stabilize airway and circulation, terminate convulsions with magnesium sulfate, urgently control sustained severe hypertension, evaluate competing neurologic diagnoses, and plan delivery after maternal stabilization rather than during uncontrolled seizure activity.

**Clinical question:** How should clinicians rapidly stabilize, treat, evaluate, and plan delivery for eclampsia during pregnancy or postpartum?

Updated: 2026-08-20T23:28:36.987822Z

## What matters in practice
- Treat a new generalized tonic-clonic, focal, or multifocal seizure during pregnancy or postpartum as eclampsia after immediate stabilization and parallel exclusion of alternative causes; hypertension and proteinuria may be absent before seizure onset. [20]
- Magnesium sulfate is first-line for seizure control and prevention of recurrence; the FDA label identifies immediate anticonvulsant onset and effective serum concentrations of 2.5–7.5 mEq/L. [3]
- Sustained severe hypertension requires prompt treatment with pregnancy-compatible agents; IV labetalol, IV hydralazine, or oral nifedipine are recommended first-line options in critical care guidance. [23]
- Delivery is definitive treatment for the underlying disorder, but maternal stabilization, seizure control, and blood pressure treatment take priority before delivery planning. [5][13]
- Do not stop surveillance after delivery: eclampsia may occur postpartum, with highest risk in the first postpartum week. [20]

## Recognize eclampsia despite incomplete preeclampsia findings

Diagnostic delay is most consequential when seizure is attributed to a nonobstetric cause without treating pregnancy-related disease.

Eclampsia is new-onset generalized tonic-clonic, focal, or multifocal seizure in a patient with a hypertensive disorder of pregnancy when another neurologic cause is not more likely. It can occur before, during, or after delivery. Although it commonly follows preeclampsia, seizures may occur without antecedent severe hypertension or proteinuria; absence of either finding must not delay magnesium sulfate or blood pressure assessment. [20]

Symptoms preceding seizure may include severe headache, visual disturbance, altered mental status, or epigastric/right upper quadrant pain, but none reliably excludes sudden eclampsia. Pregnancy-associated seizures before 20 weeks, more than 48 hours postpartum, with focal deficits, recurrent seizures, or prolonged coma warrant especially active evaluation for alternate neurologic diagnoses. [20]
- Measure blood pressure immediately and repeat promptly; severe-range hypertension is systolic blood pressure at least 160 mm Hg or diastolic blood pressure at least 110 mm Hg. [20][24]
- Obtain CBC with platelet count, serum creatinine/electrolytes, hepatic panel, and urine protein assessment while resuscitation proceeds; proteinuria is not required for preeclampsia/eclampsia. [20][24]
- Use chest imaging when pulmonary edema is suspected and obstetric ultrasound for fetal assessment after maternal stabilization. [20]
- Obtain neuroimaging for focal neurologic signs, recurrent seizures, prolonged coma, persistent headache or visual symptoms despite hypertension treatment, or atypical timing; evaluate for stroke, posterior reversible encephalopathy syndrome, cerebral venous thrombosis, and other competing diagnoses. [20][21]

*Findings that support eclampsia or demand an expanded differential diagnosis. [20][24]*

| Clinical finding | Immediate implication |
| --- | --- |
| New seizure during pregnancy or early postpartum | Initiate eclampsia management while evaluating other causes. [20] |
| Severe headache, visual symptoms, altered mental status, epigastric/right upper quadrant pain | Assess for preeclampsia severe features and neurologic or hepatic complications. [20][24] |
| Focal deficit, recurrent seizure, prolonged unconsciousness, seizure before 20 weeks or >48 hours postpartum | Add urgent neurologic evaluation and neuroimaging as clinically indicated. [20] |
| Dyspnea, rales, hypoxemia, or clinical volume overload | Assess for pulmonary edema and cardiac dysfunction; avoid unnecessary volume loading. [13][20] |

## Stabilize the mother and stop the seizure first

Management is simultaneous resuscitation, anticonvulsant therapy, and treatment of severe hypertension.

During active seizure, protect the patient from injury, position laterally when feasible, maintain oxygenation and airway patency, establish IV access, and assess maternal cardiopulmonary status. Continuous fetal monitoring is appropriate once maternal resuscitation permits, but fetal intervention should not supersede maternal stabilization. Eclampsia is an obstetric emergency requiring coordinated obstetric, anesthesia, and critical care management. [20]

Magnesium sulfate is first-line therapy for eclamptic seizure treatment and recurrence prevention. FDA labeling states that IV anticonvulsant activity is immediate and lasts about 30 minutes; serum magnesium concentrations typically sufficient to control convulsions range from 2.5 to 7.5 mEq/L. [3] The supplied FDA label does not provide a loading or maintenance dose in the available excerpt; use an institutionally approved obstetric magnesium protocol rather than extrapolating from the label. [3]
- Keep injectable calcium immediately available during magnesium infusion; discontinue magnesium and reassess serum concentration if clinically significant toxicity develops. [3]
- Monitor patellar reflexes, respiratory rate, urine output, and serum magnesium concentration during infusion. Reflexes diminish above 4 mEq/L and may disappear near 10 mEq/L, where respiratory paralysis is a major hazard. [3]
- Patients with urine output below 100 mL per 4 hours or progressive creatinine elevation are at increased risk of magnesium toxicity; the label recommends discontinuing infusion when urine output is below this threshold. [3]
- Magnesium is contraindicated in known myasthenia gravis because it can precipitate myasthenic crisis. [3]
- Avoid coadministration with neuromuscular blockers without close respiratory and train-of-four monitoring; magnesium can potentiate and prolong blockade. [3]
- Monitor closely with dihydropyridine calcium-channel blockers because exaggerated hypotension has been reported. [3]

### Control sustained severe hypertension

In pregnancy-associated hypertensive emergency, rapidly treat sustained blood pressure of at least 160/110 mm Hg. In a critical care setting, NICE identifies labetalol (oral or IV), oral nifedipine, and IV hydralazine as immediate treatment options, with response monitoring for blood pressure reduction and adverse effects. [23] The FDA magnesium label also warns against coadministration with unapproved tocolytics, including terbutaline or nifedipine, because pulmonary edema and hypotension have occurred; this warning concerns tocolytic coadministration and does not replace obstetric severe-hypertension protocols. [3]

Avoid ACE inhibitors, angiotensin receptor blockers, direct renin inhibitors, and nitroprusside during pregnancy-associated hypertensive emergency; NICE identifies these as contraindicated in eclampsia or preeclampsia. [23]

*Magnesium sulfate safety surveillance during eclampsia treatment. [3]*

| Monitor | Concerning finding | Action supported by labeling |
| --- | --- | --- |
| Respiratory status | Respiratory depression or decreasing rate | Stop infusion for significant toxicity; support ventilation and give injectable calcium salt. [3] |
| Deep-tendon reflexes | Diminished reflexes >4 mEq/L; absent reflexes near 10 mEq/L | Reassess for toxicity and serum magnesium concentration. [3] |
| Urine output | <100 mL over 4 hours | Discontinue infusion to reduce toxicity risk, especially with rising creatinine. [3] |
| Renal function | Severe renal impairment or oliguria | Reduce dosage; magnesium is renally excreted. [3] |

## Plan delivery after maternal stabilization

Delivery stops the pregnancy-specific disease process but does not immediately eliminate maternal risk.

Delivery is the definitive treatment for preeclampsia/eclampsia. In eclampsia, control seizures, stabilize airway and oxygenation, and initiate severe-hypertension treatment before proceeding with delivery planning; the route and timing of delivery depend on maternal stabilization, gestational age, fetal status, and obstetric circumstances. [5][13][20]

NICE advises IV magnesium sulfate for a woman with eclampsia in critical care and recommends selecting mode of birth according to clinical circumstances and the woman’s preference. [23] For preterm planned birth in preeclampsia, provide antenatal corticosteroids and magnesium sulfate when indicated; delivery should not be delayed when there is maternal or fetal deterioration. [23][24]
- Escalate to critical care for severe hypertension, severe preeclampsia, or eclampsia when organ dysfunction, respiratory compromise, or intensive monitoring is required. [23]
- Limit maintenance fluids in severe preeclampsia to 80 mL/hour unless there are other ongoing losses; avoid routine volume expansion except when IV hydralazine is used antenatally. [23]
- Pulmonary edema in preeclampsia is associated with endothelial permeability, cardiac dysfunction, corticosteroid/tocolytic exposure, and iatrogenic volume overload. [13]
- Maternal indications for expedited birth include uncontrolled hypertension despite multiple antihypertensive classes, progressive renal/hepatic/hematologic dysfunction, persistent neurologic features or eclampsia, placental abruption, and serious fetal compromise. [23]

*Delivery decisions in eclampsia and severe preeclampsia are driven by maternal stabilization and evidence of deterioration. [23][24]*

| Situation | Clinical priority |
| --- | --- |
| Active eclamptic seizure | Stabilize airway, stop seizure with magnesium sulfate, assess severe hypertension, then proceed to delivery planning. [20][23] |
| Eclampsia or ongoing severe neurologic features | Treat as a critical care indication; delivery is generally indicated after stabilization. [23][24] |
| Preterm disease with stable maternal and fetal status | Individualize expectant management in a center capable of maternal-fetal surveillance; give corticosteroids and magnesium when indicated. [23][24] |
| Pulmonary edema, abruption, worsening laboratory abnormalities, uncontrolled hypertension, or nonreassuring fetal status | Expedite delivery after maternal stabilization. [23][24] |

## Maintain surveillance after delivery

Postpartum onset and deterioration are common sources of missed diagnosis.

Eclampsia can occur postpartum, most often within 48 hours after delivery, with highest risk during the first postpartum week. [20] New-onset postpartum preeclampsia should be considered with hypertension arising 48 hours to 6 weeks after delivery, particularly when severe features are present. [21]

For women with preeclampsia after birth, NICE recommends frequent inpatient blood pressure measurement, symptom assessment for severe headache and epigastric pain at each measurement, and post-discharge monitoring based on antihypertensive treatment status. [23] This surveillance is clinically important because postpartum blood pressure often worsens on days 3 to 7. [21]
- Assess for severe headache, visual symptoms, epigastric pain, dyspnea, chest pain, edema, and neurologic change; refractory or thunderclap headache or headache with focal deficits, seizure, visual disturbance, or altered mental status requires evaluation for alternate cerebrovascular diagnoses. [21]
- For postpartum preeclampsia without antenatal antihypertensive treatment, NICE recommends starting therapy at blood pressure 150/100 mm Hg or higher. [23]
- For sustained severe postpartum hypertension, ACOG-referenced guidance supports rapid-acting therapy with IV labetalol, IV hydralazine, or oral nifedipine within 30–60 minutes. [21]
- Breastfeeding is compatible with antihypertensive treatment. NICE recommends enalapril with maternal creatinine and potassium monitoring and advises avoiding ARBs or diuretics where possible during breastfeeding. [23]
- At 6–8 weeks postpartum, reassess blood pressure and residual proteinuria; persistent proteinuria warrants later kidney-function review. [23]

### Long-term implications

A history of hypertensive disorders of pregnancy is associated with later hypertension and cardiovascular disease. NICE recommends counseling regarding smoking avoidance, healthy lifestyle, weight management, and cardiovascular risk reduction. [23] Eclampsia is also associated with increased future preeclampsia risk and low absolute but increased risk of later seizure disorders. [20]

*Postpartum monitoring actions for preeclampsia. [21][23]*

| Time frame | Monitoring and action |
| --- | --- |
| Inpatient after preeclampsia | Measure blood pressure at least 4 times daily; ask about severe headache and epigastric pain at each assessment. [23] |
| Days 3–5 postpartum | Ensure blood pressure assessment because postpartum worsening is common. [21][23] |
| After community transfer | Women on antihypertensives require blood pressure assessment every 1–2 days for up to 2 weeks in NICE guidance. [23] |
| 6–8 weeks postpartum | Medical review and urine dipstick; persistent proteinuria requires further kidney assessment. [23] |

## Link placental disease to maternal neurologic injury

Mechanism matters because seizures may occur without extreme hypertension.

The dominant model begins with abnormal trophoblast invasion and incomplete spiral-artery remodeling, producing placental ischemia and release of antiangiogenic factors, particularly soluble fms-like tyrosine kinase-1 and soluble endoglin. These factors disrupt vascular endothelial growth factor and transforming growth factor-β signaling, promoting systemic endothelial dysfunction, vasoconstriction, oxidative stress, and multiorgan injury. [13]

For eclampsia, impaired cerebral autoregulation and blood-brain barrier dysfunction are leading mechanistic explanations. Vasogenic edema and posterior reversible encephalopathy syndrome are common imaging correlates, but eclampsia can occur below severe-range blood pressure, supporting a role for endothelial injury beyond blood pressure alone. [13][20]
- Renal glomerular endotheliosis and podocyte injury explain proteinuria and reduced filtration. [13]
- Increased systemic vascular resistance and diastolic dysfunction contribute to pulmonary edema risk, particularly with excessive IV fluid administration. [13]
- Hepatic microcirculatory injury, platelet activation/consumption, and microangiopathy underlie HELLP-spectrum findings. [13]

*Mechanistic findings that alter clinical interpretation. [13][20]*

| Mechanism | Clinical consequence |
| --- | --- |
| Endothelial dysfunction from placental antiangiogenic factors | Multisystem involvement can occur without proteinuria. [13] |
| Cerebral autoregulatory and blood-brain barrier dysfunction | Seizure, vasogenic edema, and posterior reversible encephalopathy syndrome; image when neurologic course is atypical or persistent. [13][20] |
| Renal endothelial and podocyte injury | Proteinuria, creatinine elevation, and magnesium accumulation risk when renal clearance falls. [3][13] |
| Elevated afterload with capillary leak and volume shifts | Pulmonary edema risk; use fluids judiciously and assess volume status. [13][23] |

## Common questions

### Can eclampsia occur without proteinuria or severe hypertension?

Yes. Eclampsia may occur without preceding proteinuria or severe hypertension; treat a new seizure in pregnancy or postpartum as eclampsia while evaluating competing neurologic causes. [20]

### What is the first-line anticonvulsant for eclampsia?

IV magnesium sulfate is first-line for seizure treatment and prevention of recurrence. Monitor respiratory status, reflexes, urine output, and magnesium concentration, particularly with renal impairment. [3][20]

### When should neuroimaging be obtained in eclampsia?

Obtain neuroimaging for focal deficits, recurrent seizures, prolonged coma, persistent headache or visual symptoms despite treatment, or atypical onset before 20 weeks or more than 48 hours postpartum. [20][21]

### Does delivery occur immediately during an eclamptic seizure?

No. First stabilize the mother, control seizure activity, and address severe hypertension. Delivery is definitive treatment but should follow maternal stabilization and individualized obstetric assessment. [5][13][20]

### How long after delivery can postpartum eclampsia occur?

Risk is highest in the first postpartum week, although postpartum preeclampsia is considered with new-onset hypertension from 48 hours through 6 weeks after delivery. [20][21]

## References
1. highlights of prescribing information — dailymed.nlm.nih.gov — https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=eaf135b6-e378-4f62-a1e7-db45e23668c7&type=display
2. These highlights do not include all the information needed to use Irbesartan and Hydrochlorothiazide safely and effectively. See full prescribing information for Irbesartan and Hydrochlorothiazide.
 
      
Irbesartan and Hydrochlorothiazide tablets, for oral use
 
Initial U.S. Approval: 1997 — dailymed.nlm.nih.gov — https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=89701339-861a-4e54-a3d6-cf84046e54f2&type=display
3. DailyMed - MAGNESIUM SULFATE IN DEXTROSE- magnesium sulfate heptahydrate injection, solution — dailymed.nlm.nih.gov — https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4876dcd9-5e8f-47ed-af4f-6a4009ccffd1
4. DailyMed - MAGNESIUM SULFATE IN DEXTROSE- magnesium sulfate injection — dailymed.nlm.nih.gov — https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8da9c33f-e3cd-4026-b034-2b964401b346
5. Predictive Value of the sFlt-1:PlGF Ratio in Women with ... — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMoa1414838
6. Pre-eclampsia - Symptoms, diagnosis and treatment | BMJ Best Practice — bestpractice.bmj.com — https://bestpractice.bmj.com/topics/en-us/326
7. Strengthening global pre-eclampsia diagnosis — www.thelancet.com — https://www.thelancet.com/journals/lanogw/article/PIIS3050-5038(26)00057-9/abstract
8. Placental growth factor testing to assess women with ... — www.thelancet.com — https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)33212-4/fulltext
9. Treatment for Mild Chronic Hypertension during Pregnancy — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMoa2201295
10. HELLP syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice US — bestpractice.bmj.com — https://bestpractice.bmj.com/topics/en-us/1000
11. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/hyp.0000000000000065
12. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIR.0000000000001356
13. Preeclampsia—Pathophysiology and Clinical Presentations: 
JACC State-of-the-Art Review — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2020.08.014
14. fact sheet for healthcare providers: emergency use ... — go.nature.com — https://go.nature.com/3zbxvqg
15. The Prediction of Pre-Eclampsia Using Low Fetal... — journals.lww.com — https://journals.lww.com/01445494-202602000-00010
16. A review of clinical practice guidelines on the management of preeclampsia and nursing inspiration — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC11650664
17. Preeclampsia: Narrative review for clinical use — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10009735
18. Quality and Content Concordance of International Clinical Guidelines on Hypertensive Disorders of Pregnancy Using the AGREE II Instrument: An Updated Systematic Review — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10380410
19. Hypertensive Disorders of Pregnancy: A Systematic Review of International Clinical Practice Guidelines - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC4249974
20. Eclampsia - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK554392
21. Postpartum preeclampsia or eclampsia: defining its place ... — www.ajog.org — https://www.ajog.org/article/S0002-9378(20)31201-1/fulltext
22. Hypertension In Pregnancy - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK430839
23. Hypertension in pregnancy: diagnosis and management - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK546004
24. Preeclampsia - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK570611

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.